| Literature DB >> 32456276 |
Dunja Hasic1, Roberto Lorbeer2,3, Robert C Bertheau4, Jürgen Machann5,6,7, Susanne Rospleszcz8, Johanna Nattenmüller4, Wolfgang Rathmann9, Annette Peters3,8,10, Fabian Bamberg1, Christopher L Schlett1,11.
Abstract
The objective of the current study was to assess the relationship of bone marrow adipose tissue (BMAT) content to abdominal fat depots, including visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT), as well as cardiovascular risk factors (CVRF) beyond physical activity in a population-based cohort study undergoing whole-body magnetic resonance (MR) imaging. Subjects of the Cooperative Health Research in the Augsburg Region (KORA) FF4 study without known cardiovascular disease underwent fat fraction quantification in vertebrae (BMATL1/L2) via a 2-point T1-weighted volumetric interpolated breath-hold examination (VIBE) Dixon sequence. The same MR sequence was applied to quantify VAT and SAT volume. Subjects' characteristics, including physical activity, were determined through standardized exams and self-assessment questionnaires. Univariate and multivariate linear regression were applied. In the cohort of 378 subjects (56 ± 9.1years; 42.1% female), BMATL1/L2 was 54.3 ± 10.1%, VAT was 4.54 ± 2.71 L, and SAT was 8.10 ± 3.68 L. VAT differed significantly across BMATL1/L2 tertiles (3.60 ± 2.76 vs. 4.92 ± 2.66 vs. 5.11 ± 2.48; p < 0.001), there was no significant differences for SAT (p = 0.39). In the fully adjusted model, VAT remained positively associated with BMATL1/L2 (β = 0.53, p = 0.03). Furthermore, BMATL1/L2 was associated with age (β = 5.40 per 10-years, p < 0.001), hemoglobin A1c (HbA1c; β = 1.55 per 1%, p = 0.04), lipids (β = 0.20 per 10 mg/dL triglycerides; β = 0.40 per 10 mg/dL low-density lipoprotein (LDL); β =-3.21 lipid-lowering medication; all p < 0.05), and less physical activity (β = 3.7 "no or nearly no exercise" as compared to "≥2 h per week, regularly", p = 0.003); gender was not significantly different (p = 0.57). In the population-based cohort, VAT but not SAT were associated with higher BMATL1/L2 independently of physical activity and other cardiovascular risk factors. Further, BMATL1/L2 increased with older age, less physical activity, higher HbA1c, and increased lipids but decreased with lipid-lowering medication.Entities:
Keywords: bone marrow; magnetic resonance imaging; metabolic disease; subcutaneous adipose tissue; visceral adipose tissue
Mesh:
Substances:
Year: 2020 PMID: 32456276 PMCID: PMC7284541 DOI: 10.3390/nu12051527
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Illustration of the fat measurements in 3 Tesla whole-body magnetic resonance imaging (MRI). For all derived fat depots, a coronal 2-point Dixon T1-weighted sequence was used. The left panel shows the measurements of vertebral and femoral bone marrow adipose tissue content (BMATL1/L2 and BMATfemoral, respectively) by placing a region of interest in the fat and water image and calculating a ratio. The right panel shows the segmentation of subcutaneous adipose tissue (SAT; light yellow) and visceral adipose tissue (VAT; red) of an a 61-year-old male (body mass index (BMI) 29.7 kg/m²).
Characteristics of the entire cohort study.
| All | Lower Tertile BMATL1/L2 | Mid | Higher Tertile BMATL1/L2 | ||
|---|---|---|---|---|---|
| (15.7–50.7%) | (50.8–59.1%) | (59.2–78.2%) | |||
|
| 378 | 126 | 126 | 126 | |
| Age (years) | 56.0 (±9.1) | 50.6 (±7.9) | 56.9 (±8.7) | 60.6 (±7.6) | <0.001 |
| Female (%) | 159 (42.1%) | 54 (42.9%) | 48 (38.1%) | 57 (45.2%) | 0.51 |
| BMI (kg/m2) | 28.1 (±4.8) | 27.7 (±5.2) | 28.7 (±5.1) | 27.9 (±4) | 0.22 |
| Glucose tolerance | 0.02 | ||||
| Normal glucose tolerance | 230 (60.9%) | 90 (71.4%) | 67 (53.2%) | 73 (57.9%) | |
| Prediabetes | 95 (25.1%) | 27 (21.4%) | 38 (30.2%) | 30 (23.8%) | |
| Diabetes | 53 (14.0%) | 9 (7.1%) | 21 (16.7%) | 23 (18.3%) | |
| HbA1c (%) | 5.6 (±0.7) | 5.4 (±0.8) | 5.7 (±0.7) | 5.7 (±0.7) | <0.001 |
| Hypertension | 127 (33.6%) | 30 (23.8%) | 48 (38.1%) | 49 (38.9%) | 0.02 |
| Systolic RR (mmHg) | 121.1 (±16.6) | 117.5 (±16.5) | 122.2 (±18.0) | 123.5 (±14.7) | 0.01 |
| Diastolic RR (mmHg) | 75.6 (±9.9) | 74.3 (±9.8) | 76.6 (±10.8) | 76.0 (±9.0) | 0.16 |
| Antihypertensive medication | 93 (24.6%) | 22 (17.5%) | 32 (25.4%) | 39 (31%) | 0.04 |
| Triglyceride levels (mg/dL) | 132.4 (±85.8) | 112.1 (±62.3) | 138 (±85.9) | 147 (±101.4) | 0.003 |
| Total cholesterol (mg/dL) | 217.9 (±36.2) | 205.7 (±31.6) | 220.9 (±36.3) | 227.1 (±37.5) | <0.001 |
| HDL (mg/dL) | 61.6 (±17.4) | 62.0 (±18.4) | 60.5 (±17.8) | 62.1 (±16.1) | 0.72 |
| LDL (mg/dL) | 140 (±32.9) | 130.4 (±27.8) | 143.5 (±35.0) | 146 (±33.6) | 0.001 |
| Lipid lowering medication | 38 (10.1%) | 7 (5.6%) | 11 (8.7%) | 20 (15.9%) | 0.02 |
| Smoking status | 0.15 | ||||
| Non-smoker | 138 (36.5%) | 57 (45.2%) | 39 (31%) | 42 (33.3%) | |
| Ex-smoker | 163 (43.1%) | 48 (38.1%) | 60 (47.6%) | 55 (43.7%) | |
| Current-smoker | 77 (20.4%) | 21 (16.7%) | 27 (21.4%) | 29 (23%) |
BMAT denotes bone marrow adipose tissue; BMI, body-mass-index; HbA1c, hemoglobin A1c; RR, arterial blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
Figure 2Forrest-plot demonstrating the multivariate association of demographics and risk factors with vertebral bone marrow adipose tissue (BMATL1/L2). BMI denotes body-mass-index; HbA1c, hemoglobin A1c; LDL, low-density lipoprotein.
Univariate and multivariate associations of vertebral bone marrow adipose tissue (BMATL1/L2) with visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT). The simple model included age, sex, and physical activity, whereas the fully adjusted model included age, sex, physical activity, diabetes status, hypertension, triglyceride, LDL-cholesterol, and lipid lowering medication.
| Vertebral Bone Marrow Adipose Tissue (BMATL1/L2) | ||
|---|---|---|
| β (95% CI) | ||
| Visceral Adipose Tissue (VAT) | ||
| Univariate | 1.07 (0.71–1.43) | <0.001 |
| Simple model | 0.66 (0.25–1.06) | 0.002 |
| Fully adjusted model | 0.53 (0.07–1.00) | 0.03 |
| Subcutaneous Adipose Tissue (SAT) | ||
| Univariate | 0.24 (−0.04–0.52) | 0.09 |
| Simple model | 0.10 (−0.16–0.35) | 0.44 |
| Fully adjusted model | 0.03 (−0.24–0.30) | 0.80 |
Figure 3Local-weighted regression illustrated as a fitting curve. A potential saturation function can be argued between vertebral bone marrow adipose tissue (BMATL1/L2) and visceral adipose tissue (VAT); the fitting curve was smoothed.